https://www.selleckchem.com/pr....oducts/mivebresib-ab
Results Cohort 3.9% of group 1, 5% of group 2, and 8.4% of group 3 screened for the A4 trial. Significant differences were found among the groups (P less then 0.001). Post hoc analyses showed differences in A4 screening rates between groups 1 and 3 (P less then 0.001) and groups 2 and 3 (P = 0.0194). There were no differences in enrollment among the three groups. RCT 2.78% of the intervention group screened for A4 compared to 0% of controls (P = 0.0611). Discussion Online education via the AlzU.org digital tool may serve as
Gefällt mir
Kommentar
Teilen
